We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNCW
601
DELISTED
noco-noco Inc. Warrant
NCNCW
$876 ﹤0.01%
87,609
NIVFW
602
NewGenIvf Group Warrants
NIVFW
$840 ﹤0.01%
50,000
MSSAW
603
DELISTED
Metal Sky Star Acquisition Corporation Warrant
MSSAW
$840 ﹤0.01%
+100,000
New +$900
ADNWW
604
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$809 ﹤0.01%
93,018
COEPW
605
DELISTED
Coeptis Therapeutics Warrants
COEPW
$684 ﹤0.01%
45,600
+100
+0.2% +$2
ZCARW
606
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$643 ﹤0.01%
+37,400
New +$580
GTM
607
CALL
ZoomInfo Technologies
GTM
$861M
$597 ﹤0.01%
23,900
BROGW
608
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$532 ﹤0.01%
147,986
+100
+0.1%
ETHZW
609
DELISTED
ETHZilla Corp Warrant
ETHZW
$505 ﹤0.01%
71,715
-200
-0.3% -$2
ZAPPW
610
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
$493 ﹤0.01%
49,800
-149,813
-75% -$2.61K
CTV.WS
611
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$482 ﹤0.01%
+12,000
New +$460
BOCNW
612
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$396 ﹤0.01%
24,600
-100
-0.4% -$2
ATMCW
613
DELISTED
AlphaTime Acquisition Corp Warrant
ATMCW
$361 ﹤0.01%
30,100
CCTSW
614
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$282 ﹤0.01%
12,081
BNIXW
615
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$203 ﹤0.01%
10,165
MGNI icon
616
CALL
Magnite
MGNI
$2.65B
$105 ﹤0.01%
+100
New +$1.36K
ABUS icon
617
Arbutus Biopharma
ABUS
$865M
-20,000
Closed -$61.8K
ACET icon
618
Adicet Bio
ACET
$72.8M
-50,081
Closed -$970K
AMWL icon
619
American Well
AMWL
$181M
-12,500
Closed -$81.2K
ANGI icon
620
Angi Inc
ANGI
$224M
-13,913
Closed -$267K
ARKK icon
621
ARK Innovation ETF
ARKK
$5.89B
-275,950
Closed -$12.1M
ARQQ icon
622
Arqit Quantum
ARQQ
$290M
-4,000
Closed -$34.2K
AVPTW
623
DELISTED
AvePoint Inc Warrant
AVPTW
-45,810
Closed -$79.7K
BETR icon
624
Better Home & Finance Holding
BETR
$412M
-3,000
Closed -$68.8K
BNY
625
Bank of New York Mellon
BNY
$108B
-7,500
Closed -$493K

Similar funds

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.